Back to search

University of Ioannina

Ο έλεγχος θρομβοφιλίας με πηκτικολογικές μεθόδους και αλυσιδωτή αντίδραση πολυμεράσης (PCR) σε ασθενείς τριτοβάθμιου νοσοκομείου

Abstract

dc:description

Ischemic stroke (IS) is a leading cause of death in developed countries; its prevalenceamong young adults (aged 18 to 50 years) ranges from 3% to 5%.The potential reduction in quality of life, as well as the obvious long-term significantsocioeconomic consequences urges for efficient primary and secondary prevention so as tofacilitate the likelihood of an increased number of productive years with good quality of life.IS is a heterogenous, multifactorial disease caused by conventional vascular risk factors andgenetic factors. Over the last years several studies have been performed to elucidate the mechanisms ofthis ischemic event. The well-established risk factors of hypertension, obesity and smoking,account for only a small percentage of cerebrovascular events.Common variations in the genes encoding factor V, prothrombin, 5,10methylenetetrahydrofolate reductase (MTHFR), factor XIII and plasminogen activatorinhibitor-1 are clotting factor mutations or polymorphisms that are associated with anincreased tendency towards thrombosis. The evidence of a role for these variants in the risk ofischemic stroke is controversial.In young adults with a history of ischemic stroke, we evaluated the role of theseinherited prothrombotic factors.The aim of the study was to investigate and compare the prevalence of theaforementioned classic vascular risk factors and polymorphisms, that is FVLeiden R506Q(FVL), the prothrombin variant (allele 20210A, FIIG20210A), C677T MTHFR(C677TMTHFR) polymorphism, the insertion/deletion (4G/5G) variation (-6754G/5GPAI-1)as well as the single nucleotide polymorphism -844G/A of in the plasminogen activatorinhibitor-1 (-844G/APAI-1) gene promoter and factor XIIIA Val34Leu polymorphism(FXIIIAVal34leu)and the impact of these gene mutations and classic vascular risk factors on theoverall stroke risk in individuals aged 50 years or younger. We also evaluated the role ofProtein C (PrC), Protein S (PrS) and Antithrombin (AT) deficiencies.In this respect, we conducted a case control study of 51 hospital cases of first-everischemic stroke in patients and 70 community-based controls.Patients and controls did not differ regarding age (p=0.876), sex ratios (p=0.567),smoking (p=0.559), hypercholesterolemia (p=0.112) or family history of stroke (p=0.20).Hypertension was more frequent in patients (8/51, 15.7%) (p=0.0001) than in the controls(0/70, 0%) (p=0.0001). All the patients and all the control subjects were of Caucasian origin(same ethnic background population).The prevalence of FVL, FIIG20210A, C677T MTHFR gene mutations, -6754G/5GPAI, -844G/A PAI-1 and FXIII-AVal34leu polymorphisms, as well as the plasma levelsof PrC, PrS and AT were assessed (after being tested by Polymerase ChainReaction/molecular techniques and clotting assays) and compared with controls.As data regarding strokes in young adults from Greece is scarce, the present study hasbeen carried out with the aim to test the possible association between -675 4G/5G PAI-1polymorphism, FVL, FIIG20210A, MTHFR C677T, the -844G/A PAI-1 single nucleotide polymorphism (SNP) and polymorphism FXIIIA Val34leu with ischemic stroke in the youngage in this specific South European population. We further evaluated the role of plasma levelsof PrC, PrS and AT.As this is the first study of this kind in Greek population, the additional goal was to evaluatethe importance of these mutations as risk factors for development of IS in the young age aswell as the prevalence of these mutations to the general population.In our setting of patients with young adult ischemic stroke, we came to the followingconclusions:No significant difference was found between patients and controls regarding thedistribution of FVL (p=0.199 ), FIIG20210A (p= 0.410), MTHFR (p= 0.788), -844G/A PAI-1(p=0.493) and FXIII-AVal34leu (p= 0.160) mutations/polymorphisms.These data are compatible with several reports showing that the presence of theabovementioned variants is not associated with an increased risk of ischemic stroke in theyoung age. However, they are at variance with other studies which showed some association. The 4G/5G genotype of the -675 4G/5G was significantly more frequent amongpatients as compared to controls. Moreover, we found a significantly lower frequency of the5G/5G genotype in patients as compared to control subjects. (p=0.02)Hence, this study suggests that the polymorphism of the PAI-1 gene promoter is agenetic risk factor for IS in the young age.We failed to demonstrate a significant association between patients and controlsregarding the rest of the inherited thrombophilia risk factors screened. Thus, those factors werenot found to increase the risk of IS among the group of young patients of Caucasian origin westudied.Further studies including all incoming young patients with IS are necessary to evaluatethe impact of those variants as risk factors in IS in the young age. Moreover, other novelgenetic defects and/or environmental factors could play a role and need to be investigated

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ranellou, Kyriaki
  • Ρανέλλου, Κυριακή

Subjects

dc:subject × 17

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43447

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ranellou, Kyriaki; Ρανέλλου, Κυριακή. Ο έλεγχος θρομβοφιλίας με πηκτικολογικές μεθόδους και αλυσιδωτή αντίδραση πολυμεράσης (PCR) σε ασθενείς τριτοβάθμιου νοσοκομείου. University of Ioannina, 2015. http://hdl.handle.net/10442/hedi/43447